GlassScriptPhysician profile
Michael J Peterson
NPI 1144885575
$2,026.84
in general payments reported to CMS, 2019-2025
22 companies · $695 in 2025
The $695 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $294 · 2022: $246 · 2023: $282 · 2024: $510 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,486.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $434.59 | 2021-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $396.44 | 2024-2025 | |
| Medtronic, INC. | $224.93 | 2021-2025 | Venaseal, Kyphon Express II Kyphopak Tray |
| Novo Nordisk INC | $133.25 | 2024-2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $112.70 | 2024-2025 | Lokelma, Farxiga |
| Merck Sharp & Dohme LLC | $106.80 | 2022-2025 | Verquvo, Steglatro, Januvia |
| Boston Scientific Corporation | $94.31 | 2024-2025 | Varithena Administration Pack |
| Edwards Lifesciences Corporation | $86.82 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.10 | 2023-2024 | Lifevest |
| Alnylam Pharmaceuticals INC. | $79.02 | 2023-2025 | Amvuttra |
| Kiniksa Pharmaceuticals, LTD. | $41.90 | 2022-2023 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $39.79 | 2025 | Uptravi, Opsynvi |
| Lexicon Pharmaceuticals, INC. | $24.68 | 2023 | Inpefa |
| Pfizer INC. | $22.91 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.60 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $21.36 | 2024 | Arcalyst |
| Abiomed | $21.30 | 2025 | |
| W. L. Gore & Associates, INC. | $18.42 | 2023 | Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Chiesi USA, INC. | $16.39 | 2025 | Juxtapid |
| Genzyme Corporation | $15.98 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $14.34 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.21 | 2023 | Livalo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.